Models for 10,000 Human Diseases
A Strong Foundation Makes For A Strong House: New Understandings in Embryonic Epithelial Development
In an article published in genengnews.com, the findings of a research study “Topological Morphogenesis of Neuroepithelial Organoids” discovered new information about cell-to-cell tissue connectivity that provides an organizational backbone for further organ...
Tempo-iKidneyPod™: Modeling with Microfluidics
Tempo-iKidneyPod™ was mentioned in springer.com in a review article that summarized various investigative methods and applications of microfluidic chips, specifically to examine how SARS-CoV-2 causes acute kidney injury (AKI). Tempo-iKidneyPod™ is composed of human...
Sources of cells for modeling the human BBB — 4 considerations
Welcome to Part 3 of our blog series covering the blood brain barrier (BBB). In Part 1, we looked briefly at how the BBB was discovered and presented what we currently know about its composition and functions. Part 2 focused on the need for reliable BBB models in drug...
In Vitro Blood Brain Barrier Models for Drug Development
Welcome back to our blog series about the blood brain barrier (BBB). In Part 1, we provided a brief history on the discovery of the BBB, and introduced what we currently know about its composition and biological functions. In Part 2, we explain why reliable BBB models...
Tempo-iMG™ and Tempo-iOligo™: Two New Puzzle Pieces
Tempo-iMG™ and Tempo-iOligo™ were cited by scientists in a nature.com study where they built a 3D in vitro organoid model of the blood brain barrier (BBB). They chose to build their BBB model based on a composition of multiple neural and glial cell types. By utilizing...
Tempo Bioscience Services
Disease Models and Assay Services
Tempo offers services and alliances based on our advanced technological platforms and a range of capabilities. Our team differentiates ourselves based on a strong commitment to innovative solutions and quality R&D for our partners.
Tempo Bioscience Support
On Demand Custom Engineered Cell Models
Tempo develops patient relevant stem cell (iPSCs) based models to support drug discovery, preclinical studies, and early-stage clinical development.